PAVmed Inc. Made Headway

Fri, Feb 14, 2020 at 05:30 PM

PAVmed Inc. (PAVM:NASDAQ) jumped higher at $2.46, representing a gain of 32.3%. On Thu 13 Feb 20, PAVM:NASDAQ touched a New 2-Week High of $1.86. The stock got featured on our News Catalysts scanner on Wed 12 Feb 20 at 03:15 PM in the 'BIOTECH' category. From Fri 24 Jan 20, the stock recorded 57.14% Up Days and 40.00% Green Days

About PAVmed Inc. (PAVM:NASDAQ)

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency.

Top 10 Gainers:

Summer Infant, Inc. (SUMR:NASDAQ), 288.03%
Genprex, Inc. (GNPX:NASDAQ), 56.2%
BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 55.01%
Zosano Pharma Corporation (ZSAN:NASDAQ), 38.55%
Digital Ally, Inc. (DGLY:NASDAQ), 34.89%
PAVmed Inc. (PAVM:NASDAQ), 32.26%
ImmunoGen, Inc. (IMGN:NASDAQ), 26.87%
Huitao Technology Co., Ltd. (HHT:NASDAQ), 24.18%
The Chemours Company (CC:NYSE), 23.53%
scPharmaceuticals Inc. (SCPH:NASDAQ), 21.86%